A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of withania somnifera - PubMed (original) (raw)
. 2000 Jul;42(3):295-301.
Affiliations
- PMID: 21407960
- PMCID: PMC2958355
A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of withania somnifera
C Andrade et al. Indian J Psychiatry. 2000 Jul.
Abstract
A double-blind, placebo-controlled study was conducted to evaluate the efficacy an ethanolic extract of Aswagandha (Withania somnifera), in patients with ICD-10 anxiety disorders. The sample comprised 39 subjects, of whom 20 received the drug and 19 received placebo. The two groups were sociodemographically and clinically similar at baseline. At 2 and 6 weeks follow-up, data from approximately 85% of patients in each group were available for analysis. Statistical trends favouring the drug were observed at both time points. At 6 weeks, significantly more patients met a priori response criteria in the drug group (88.2%) as compared with the placebo group (50%). The drug was well-tolerated and did not occasion more adverse effects than did placebo. It is concluded that this ethanolic extract of Withania somnifera has useful anxiolytic potential and merits further investigation.
Keywords: Anxiety disorder; Aswagandha; Ayurvedic treatment; adjustment disorder with anxiety; clinical trial; generalized anxiety disorder; herbal therapy; panic disorder.
Similar articles
- Assessment of the Efficacy of Withania somnifera Root Extract in Patients with Generalized Anxiety Disorder: A Randomized Double-blind Placebo- Controlled Trial.
Fuladi S, Emami SA, Mohammadpour AH, Karimani A, Manteghi AA, Sahebkar A. Fuladi S, et al. Curr Rev Clin Exp Pharmacol. 2021;16(2):191-196. doi: 10.2174/1574884715666200413120413. Curr Rev Clin Exp Pharmacol. 2021. PMID: 32282308 Clinical Trial. - Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial.
Jahanbakhsh SP, Manteghi AA, Emami SA, Mahyari S, Gholampour B, Mohammadpour AH, Sahebkar A. Jahanbakhsh SP, et al. Complement Ther Med. 2016 Aug;27:25-9. doi: 10.1016/j.ctim.2016.03.018. Epub 2016 Apr 9. Complement Ther Med. 2016. PMID: 27515872 Clinical Trial. - Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study.
Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Langade D, et al. Cureus. 2019 Sep 28;11(9):e5797. doi: 10.7759/cureus.5797. Cureus. 2019. PMID: 31728244 Free PMC article. - An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera).
Pratte MA, Nanavati KB, Young V, Morley CP. Pratte MA, et al. J Altern Complement Med. 2014 Dec;20(12):901-8. doi: 10.1089/acm.2014.0177. J Altern Complement Med. 2014. PMID: 25405876 Free PMC article. Review. - Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK, Banerjee S, Biswas S, Das B, Kar A, Katiyar CK. Mukherjee PK, et al. J Ethnopharmacol. 2021 Jan 10;264:113157. doi: 10.1016/j.jep.2020.113157. Epub 2020 Aug 9. J Ethnopharmacol. 2021. PMID: 32783987 Review.
Cited by
- Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers.
Malík M, Tlustoš P. Malík M, et al. Plants (Basel). 2023 Mar 18;12(6):1364. doi: 10.3390/plants12061364. Plants (Basel). 2023. PMID: 36987052 Free PMC article. Review. - Biodiversity, Biochemical Profiling, and Pharmaco-Commercial Applications of Withania somnifera: A Review.
Gaurav H, Yadav D, Maurya A, Yadav H, Yadav R, Shukla AC, Sharma M, Gupta VK, Palazon J. Gaurav H, et al. Molecules. 2023 Jan 26;28(3):1208. doi: 10.3390/molecules28031208. Molecules. 2023. PMID: 36770874 Free PMC article. Review. - Natural product-based pharmacological studies for neurological disorders.
Puri V, Kanojia N, Sharma A, Huanbutta K, Dheer D, Sangnim T. Puri V, et al. Front Pharmacol. 2022 Nov 7;13:1011740. doi: 10.3389/fphar.2022.1011740. eCollection 2022. Front Pharmacol. 2022. PMID: 36419628 Free PMC article. Review. - Effects of Withania somnifera (Ashwagandha) on Stress and the Stress- Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia.
Speers AB, Cabey KA, Soumyanath A, Wright KM. Speers AB, et al. Curr Neuropharmacol. 2021;19(9):1468-1495. doi: 10.2174/1570159X19666210712151556. Curr Neuropharmacol. 2021. PMID: 34254920 Free PMC article. Review. - Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective.
Saleem S, Muhammad G, Hussain MA, Altaf M, Bukhari SNA. Saleem S, et al. Iran J Basic Med Sci. 2020 Dec;23(12):1501-1526. doi: 10.22038/IJBMS.2020.44254.10378. Iran J Basic Med Sci. 2020. PMID: 33489024 Free PMC article. Review.
References
- Acta Psychiatr Scand Suppl. 1986;326:1-37 - PubMed
- Br J Psychiatry. 1998 Jul;173:54-60 - PubMed
- Am J Psychiatry. 1993 Aug;150(8):1210-5 - PubMed
- Indian J Med Res. 1991 Aug;94:312-5 - PubMed
- Arch Gen Psychiatry. 1994 Jan;51(1):8-19 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous